Portal de Periódicos da CAPES

Prolactinoma and pregnancy

2000; Wiley; Volume: 107; Issue: 9 Linguagem: Inglês

10.1111/j.1471-0528.2000.tb11101.x

1471-0528

Harpal S. Randeva, Melanie Davis, Gordana M. Prelević,

Adrenal and Paraganglionic Tumors

BJOG: An International Journal of Obstetrics & GynaecologyVolume 107, Issue 9 p. 1064-1068 Prolactinoma and pregnancy Harpal S. Randeva, Harpal S. Randeva Senior Registrar Department of Endocrinology, Royal Free and University College London Medical SchoolSearch for more papers by this authorMelanie Davis, Melanie Davis Consultant Reproductive Medicine Unit, The Obstetric Hospital, University College London Hospitals, LondonSearch for more papers by this authorGordana M. Prelevic, Gordana M. Prelevic Senior Lecturer and Consultant Department of Endocrinology, Royal Free and University College London Medical SchoolSearch for more papers by this author Harpal S. Randeva, Harpal S. Randeva Senior Registrar Department of Endocrinology, Royal Free and University College London Medical SchoolSearch for more papers by this authorMelanie Davis, Melanie Davis Consultant Reproductive Medicine Unit, The Obstetric Hospital, University College London Hospitals, LondonSearch for more papers by this authorGordana M. Prelevic, Gordana M. Prelevic Senior Lecturer and Consultant Department of Endocrinology, Royal Free and University College London Medical SchoolSearch for more papers by this author First published: 12 August 2005 https://doi.org/10.1111/j.1471-0528.2000.tb11101.xCitations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Jacobs HS, Franks S, Murray MAF, Hull MGR, Steele SJ, Nabarro JDN. Clinical and endocrine features of hyperprolactinaemic amenorrhoea. Clin Endocrinol 1976; 5: 439– 454. 2 Moult PGA, Dacie JE, Rees LH, Besser GM. Prolactin pulsatility in patients with gonadal dysfunction. Clin Endocrinol 1981; 14: 387– 394. 3 Vance ML, Evans WS, Thorner MO. Drugs five years later: bromocriptine. Ann Intern Med 1984; 100: 78– 91. 4 Biller BM, Baum HB, Rosenthall DI, Saxe VC, Charpie PM, Klibanski A. Progressive trabecular osteopenia in women with hyperprolactinemic amenorrhoea. J Clin Endocrinol Metab 1992; 75: 692– 697. 5 Horvath E, Kovacs K. The qadenohypophysis. In: K Kovacs, SL Asa, editors. Functional Endocrine Pathology. Boston : Blackwell Science, 1991: 245– 281. 6 Franks S, Nabarro JDN, Jacobs HS. Prevalence and presentation of hyperprolactinaemia in patients with 'functionless' pituitary tumours. Lancet 1977; 1: 778– 780. 7 Domingue JN, Richmond IL, Wilson CB. Results of surgery in 114 patients with prolactin-screening pituitary adenomas. Am J Obstet Gynecol 1980; 137: 102– 108. 8 Spark RF, Wills CA, O'Rielly G, Ransil BJ, Bergland R. Hyperprolactinaemia in males with and without pituitary macroadenomas. Lancet 1982; 2: 129– 132. 9 Molitch ME, Russel EJ. The pituitary 'incidentaloma'. Ann Intern Med 1990; 112: 925– 931. 10 Koppelman MCS, Jaffe MJ, Rieth KG, Caruso RC, Loriaux DL. Hyperprolactinaemia, amenorrhoea and galactorrhoea. Ann Intern Med 1984; 100: 115– 121. 11 Schlechte J, Dolan K, Sherman B, Chapler F, Luciano A. The natural history of untreated hyperprolactinaemia: a prospective analysis. J Clin Endocrinol Metab 1989; 68: 412– 418. 12 Bevan JS, Burke CW, Esiri MM, Adams CBT. Misinterpretation of prolactin levels leading to management errors in patients with sellar enlargement. Am J Med 1987; 82: 29– 32. 13 Bevan JS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumour shrinkage. Endocr Rev 1992; 13: 220– 240. 14 Molitch ME, Elton RL, Blackwell RE et al. Bromocriptine as primary therapy for prolactin-screening macroadenomas – macroadenomas results of a prospective multicenter study. J Clin Endocrinol Metab 1985; 60: 698– 705. 15 Webster J, Piscitelli G, Polli A et al. A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinaemic amenorrhoea. N Engl J Med 1994; 331: 904– 909. 16 Delgrange E, Maiter D, Donckier J. Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine. Eur J Endocrinol 1996; 134: 454– 456. 17 Asa SL, Penz G, Kovacs K, Ezrin C. Prolactin cells in the human pituitary: a quantitative immunocytochemical analysis. Arch Pathol Lab Med 1982; 106: 360– 363. 18 Gonzalez JG, Elizondo G, Saldivar D, Nanez H, Todd LE, Villarreal JZ. Pituitary gland growth during normal pregnancy: an in vivo study using magnetic resonance imaging. Am J Med 1988; 85: 217– 220. 19 Scheithauer BW, Sano T, Kovacs KT, Young WF Jr, Ryan N, Randall RV. The pituitary gland in pregnancy: a clinico-pathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 1990; 65: 461– 474. 20 Diaz S, Cardenas H, Brandeis A et al. Early differences in the endocrine profile of long and short lactational amenorrhoea. J Clin Endocrinol Metab 1991; 72: 196– 201. 21 Lloyd HM, Meares JD, Jacobi J. Effects of oestrogen and bromocriptine on in vivo secretion and mitosis in prolactin cells. Nature 1975; 255: 497– 498. 22 Gemzell C, Wang CF. Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979; 31: 363– 372. 23 Molitch ME. Pregnancy and the hyperprolactinaemic woman. N Engl J Med 1985; 312: 1364– 1370. 24 Krupp P, Monka C. Bromocriptine hi pregnancy: safety aspects. Klin Wochenschr 1987; 65: 823– 827. 25 Raymond JP, Goldstein E, Konopka P et al. Follow up of children born of bromocriptine-treated mothers. Horm Res 1985; 22: 239. 26 Espersen T, Ditzel J. Pregnancy and delivery under bromocriptine therapy. Lancet 1977; 2: 985. 27 Crosignani PG, Mattei AM, Severini V, Cavioni V, Maggioni P, Testa G. Long term effects of time, medical treatment and pregnancy in 176 hyperprolactinaemic women. Eur J Obstet Gynecol Reprod Biol 1992; 44: 175– 180. 28 Jeffcoate WJ, Pound N, Sturrock NDC, Lambourne J. Long term follow up of patients with hyperprolactinaemia. Clin Endocrinol 1996; 45: 299– 303. 29 Vance ML, Thorner MO. Prolactinomas. Endocrinol Metab Clin N Am 1987; 16: 731– 753. 30 Laws ER Jr. Pituitary surgery. Endocrinol Metab Clin N Am 1987; 16: 647– 665. 31 Ikegami H, Aono T, Koizumi K, Koike K, Fukui H, Tanizawa O. Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril 1987; 47: 867– 869. 32 Mehta AE, Reyes FI, Faiman C. Primary radiotherapy of prolactinomas. Am J Med 1987; 83: 49– 58. 33 Tsagarakis S, Grossman A, Plowman PN et al. Megavoltage pituitary irradiation in the management of prolactinomas: long term follow up. Clin Endocrinol 1991; 34: 399– 406. 34 Soule SG, Jacobs HS. Prolactinomas: present day management. Br J Obstet Gynaecol 1995; 102: 178– 181. 35 Schlechte JA. Prolactinomas. Curr Ther Endocrinol Metab 1997; 6: 45– 47. 36 Brodsky JB, Cohen EN, Brown BW Jr et al. Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 1980; 138: 1165. 37 Cosman F, Post KD, Holub DA et al. Lymphocytic hypophysitis. Review of 3 new cases and review of the literature. Medicine 1989; 68: 240– 256. Citing Literature Volume107, Issue9September 2000Pages 1064-1068 ReferencesRelatedInformation